Ask Anything
Hot Research Today
Papers from every journal, all in one place. Create custom feeds.
Guideline29 mentionsExpert CommentaryCirculation Highlight
JUN 29WalshCirculation
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
Standardizes pre-HF identification to enable targeted prevention; extends 2021 consensus for consistent research and surveillance.
Guideline26 mentionsExpert CommentaryCirculation Highlight
JUN 18LewseyCirculation
Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart Association
Tailored plans needed to improve GDMT access in older HF patients; extends recommendations to address age-specific barriers.
Guideline14 mentionsExpert CommentaryCirculation Highlight
JUN 24AdedinsewoCirculation
Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association
May inform perinatal HF care via expert consensus; leaves open standardized definitions and screening tools.
RCT · n=9484 mentionsTrending on XTrending on X
JUN 24TernacleJAMA Cardiology
TAVR shows similar 7-year rates of stage 2 or 3 SVD versus surgery in low-risk patients.
Supports comparable midterm valve durability for TAVR and surgery; leaves open need for extended follow-up data.
AJACC Journal Scan
For now, the PARTNER 3 trial durability analysis offers reassuring evidence of excellent midterm outcomes in low-risk patients. As TAVR continues to move into younger populations, understanding which durability pathways matter, and in whom, will be key to building effective lifetime valve strateg...
RCT · n=1751 mentionsExpert CommentaryACC Journal Scan Highlight
JUN 17LewisJAMA Cardiology
Aficamten monotherapy improves submaximal exercise VE/VCO2 slope by ~2.8 points vs metoprolol in symptomatic oHCM.
Aficamten may be preferred over metoprolol for exercise capacity in symptomatic obstructive HCM; extends RCT evidence for myosin inhibitors versus beta-blockade.
AJACC Journal Scan
“These findings provide compelling justification for aficamten treatment as an appropriate alternative to current first-line treatment with metoprolol, to treat exercise intolerance in oHCM.”
Guideline27 mentionsExpert CommentaryACC Journal Scan (X) Highlight
JUN 1WalshJournal of the American College of Cardiology
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
Standardized HF categories should now guide diagnosis, management, and trial design; extends prior EF classifications by incorporating improved function.
RCT · n=1,9105 mentionsFeatured in PodcastExpert Commentary
JUN 1ThouraniJournal of the American College of Cardiology
TAVR with SAPIEN XT increases 10-year all-cause mortality ~13% versus surgery.
May favor surgery over early-generation TAVR for 10-year survival in intermediate-risk patients; challenges assumptions of long-term equivalence.
DTDr. Tamim Nazif
Cardiologist, NewYork-Presbyterian/Columbia University Irving Medical Center
Taken together, the studies show a likely early advantage of TAVR with respect to the important primary clinical endpoints, with a later catch-up of surgery, such that there are no major differences between the therapies at 5 years.
Guideline1 mentionsExpert CommentaryFeatured in Podcast
JUN 9KhanCirculation
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Scientific statement examines risk assessment for improving cardiovascular disease prevention strategies.
cohort · n=117,02512 mentionsTrending on XExpert Commentary
JUN 1ZhangJournal of the American College of Cardiology
Resistance training ≥2 hours weekly in women linked to ~20% lower major CVD risk.
Observational data should not yet change practice; extends evidence on resistance training for CVD prevention in women but requires trials.
AJACC Journal Scan
These findings suggest that, within an already active population, RT is associated with additional reductions in [cardiovascular disease] risk above and beyond overall aerobic activity. Alongside aerobic activity and reductions in sedentary behavior, RT may be an important component of public hea...
Guideline18 mentionsCirculation Highlight
JUN 15BaracCirculation
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association
May enhance CV endpoint consistency in oncology trials; leaves open effects on outcomes or regulatory decisions pending validation.
